Johnson & Johnson Agrees to $2 Billion Fraud Settlement
In a massive settlement, health care juggernaut Johnson & Johnson will pay $2.2 billion for marketing drugs for unapproved uses and providing doctors and pharmacies with kickbacks. Though doctors can prescribe medications for off-label uses, companies cannot promote drugs for use in ways not approved by the FDA. Whistleblowers will receive a record $168 million in the deal, with $28 million going to one former J&J employee who was crucial to the case. Maybe J&J needs a Band-Aid for its wallet.